Literature DB >> 23319552

Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization.

Carles Ubeda1, Vanni Bucci, Silvia Caballero, Ana Djukovic, Nora C Toussaint, Michele Equinda, Lauren Lipuma, Lilan Ling, Asia Gobourne, Daniel No, Ying Taur, Robert R Jenq, Marcel R M van den Brink, Joao B Xavier, Eric G Pamer.   

Abstract

Bacteria causing infections in hospitalized patients are increasingly antibiotic resistant. Classical infection control practices are only partially effective at preventing spread of antibiotic-resistant bacteria within hospitals. Because the density of intestinal colonization by the highly antibiotic-resistant bacterium vancomycin-resistant Enterococcus (VRE) can exceed 10(9) organisms per gram of feces, even optimally implemented hygiene protocols often fail. Decreasing the density of intestinal colonization, therefore, represents an important approach to limit VRE transmission. We demonstrate that reintroduction of a diverse intestinal microbiota to densely VRE-colonized mice eliminates VRE from the intestinal tract. While oxygen-tolerant members of the microbiota are ineffective at eliminating VRE, administration of obligate anaerobic commensal bacteria to mice results in a billionfold reduction in the density of intestinal VRE colonization. 16S rRNA gene sequence analysis of intestinal bacterial populations isolated from mice that cleared VRE following microbiota reconstitution revealed that recolonization with a microbiota that contains Barnesiella correlates with VRE elimination. Characterization of the fecal microbiota of patients undergoing allogeneic hematopoietic stem cell transplantation demonstrated that intestinal colonization with Barnesiella confers resistance to intestinal domination and bloodstream infection with VRE. Our studies indicate that obligate anaerobic bacteria belonging to the Barnesiella genus enable clearance of intestinal VRE colonization and may provide novel approaches to prevent the spread of highly antibiotic-resistant bacteria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319552      PMCID: PMC3584866          DOI: 10.1128/IAI.01197-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.

Authors:  Carles Ubeda; Ying Taur; Robert R Jenq; Michele J Equinda; Tammy Son; Miriam Samstein; Agnes Viale; Nicholas D Socci; Marcel R M van den Brink; Mini Kamboj; Eric G Pamer
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

3.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

Authors:  Ju Young Chang; Dionysios A Antonopoulos; Apoorv Kalra; Adriano Tonelli; Walid T Khalife; Thomas M Schmidt; Vincent B Young
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

4.  Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation.

Authors:  Michael T Bailey; Scot E Dowd; Jeffrey D Galley; Amy R Hufnagle; Rebecca G Allen; Mark Lyte
Journal:  Brain Behav Immun       Date:  2010-10-30       Impact factor: 7.217

5.  The effect of three frequently applied antibiotics on the colonization resistance of the digestive tract of mice.

Authors:  H A Thijm; D van der Waaij
Journal:  J Hyg (Lond)       Date:  1979-06

6.  Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis.

Authors:  M Wlodarska; B Willing; K M Keeney; A Menendez; K S Bergstrom; N Gill; S L Russell; B A Vallance; B B Finlay
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

7.  Ironing out the wrinkles in the rare biosphere through improved OTU clustering.

Authors:  Susan M Huse; David Mark Welch; Hilary G Morrison; Mitchell L Sogin
Journal:  Environ Microbiol       Date:  2010-03-11       Impact factor: 5.491

8.  The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization.

Authors:  Rosana B R Ferreira; Navkiran Gill; Benjamin P Willing; L Caetano M Antunes; Shannon L Russell; Matthew A Croxen; B Brett Finlay
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

9.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

10.  RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. II. FACTORS RESPONSIBLE FOR ITS LOSS FOLLOWING STREPTOMYCIN TREATMENT.

Authors:  M BOHNHOFF; C P MILLER; W R MARTIN
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

View more
  165 in total

1.  Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community.

Authors:  María José Gosalbes; Jorge F Vázquez-Castellanos; Cécile Angebault; Paul-Louis Woerther; Etienne Ruppé; María Loreto Ferrús; Amparo Latorre; Antoine Andremont; Andrés Moya
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

2.  High Heterogeneity of Multidrug-Resistant Enterobacteriaceae Fecal Levels in Hospitalized Patients Is Partially Driven by Intravenous β-Lactams.

Authors:  Eva M González-Barberá; Jaime Sanz; Ana Djukovic; Alejandro Artacho; Iván Peñaranda; Beatriz Herrera; María José Garzón; Miguel Salavert; José Luis López-Hontangas; Karina B Xavier; Bernhard Kuster; Laurent Debrauwer; Jean-Marc Rolain; Miguel A Sanz; Joao B Xavier; Carles Ubeda
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

Review 3.  Cancer and the microbiota.

Authors:  Wendy S Garrett
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

4.  Topical Antimicrobial Treatments Can Elicit Shifts to Resident Skin Bacterial Communities and Reduce Colonization by Staphylococcus aureus Competitors.

Authors:  Adam J SanMiguel; Jacquelyn S Meisel; Joseph Horwinski; Qi Zheng; Elizabeth A Grice
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 5.  Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.

Authors:  E G Pamer
Journal:  Mucosal Immunol       Date:  2014-01-08       Impact factor: 7.313

6.  Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.

Authors:  Rafael Araos; Albert K Tai; Graham M Snyder; Martin J Blaser; Erika M C D'Agata
Journal:  Clin Infect Dis       Date:  2016-06-28       Impact factor: 9.079

7.  Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites.

Authors:  Zhi-Lan Zhou; Xue-Bing Jia; Meng-Fei Sun; Ying-Li Zhu; Chen-Meng Qiao; Bo-Ping Zhang; Li-Ping Zhao; Qin Yang; Chun Cui; Xue Chen; Yan-Qin Shen
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 8.  Intestinal microbiome changes and stem cell transplantation: Lessons learned.

Authors:  Ying Taur
Journal:  Virulence       Date:  2016-11-16       Impact factor: 5.882

Review 9.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

Review 10.  The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.

Authors:  Fozia Noor; Anne Kaysen; Paul Wilmes; Jochen G Schneider
Journal:  J Innate Immun       Date:  2018-10-04       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.